- RSS-Feed
- 2020
- Keine Einträge vorhanden
- 2019
- Keine Einträge vorhanden
- 2018
- Keine Einträge vorhanden
- 2017
- Bioengineered livers mimic natural development
- BIO CITY LEIPZIG rated under the 15 Best Biotech Incubators in Europe
- c-LEcta’s Enzyme enabled a novel enzyme cascade - the synthesis of biopolymer precursors
- 150,000 stem cell deposits at Vita 34
- c-LEcta Extended its Biodiversity Platform by Genomic Libraries from Marine Sources
- iDiv: Carnivores more seriously threatened by roads than previously acknowledged
- Fraunhofer IZI and Immunic GmbH carry out joint research on new drugs for treating autoimmune diseases
- c-LEcta starts Marketing & Distribution of DENARASE®
- 2016
- Oxytocin enhances social affiliation in chimpanzee groups
- How to make hard substrates out of soft ingredients – new research findings could revolutionize stem cell technology
- Damages caused by bears: Only humans determine frequency Number of bears negligible
- More is better: the diversity and number of soil animals determine leaf decomposition in the forest
- Major progress on global biodiversity observation system
- RIBOLUTION Health GmbH founded in Leipzig
- 2015
- 2014
- Keine Einträge vorhanden
- 2013
- Keine Einträge vorhanden
- 2012
- Keine Einträge vorhanden
- 2011
- Keine Einträge vorhanden
- 2010
- Keine Einträge vorhanden
- 2009
- Keine Einträge vorhanden
- 2008
- Keine Einträge vorhanden
- 2007
- Keine Einträge vorhanden
- 2006
- Keine Einträge vorhanden
- 2005
- Keine Einträge vorhanden
- 2004
- Keine Einträge vorhanden
c-LEcta starts Marketing & Distribution of DENARASE®
DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.
DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.
The advantages of DENARASE® are:
+ Animal product free production
+ endotoxin-free production strain
+ high purity and activity
+ compliance with cGMP
If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact c-LEcta GmbH via denarase@c-lecta.com.
Previous News
Fraunhofer IZI and Immunic GmbH carry out joint research on new drugs for treating autoimmune diseases
Fraunhofer IZI. Since January 2017, researchers from Immunic GmbH have been working with scientists at the Department of Drug Design and Target Validation of the Fraunhofer IZI in Halle (Saale) on developing new drugs. The aim is the preclinical development of one or several active candidate ingredients for treating chronically inflammatory and autoimmune diseases.
Next News
Oxytocin enhances social affiliation in chimpanzee groups
Max Planck Institute. In violent intergroup conflicts between chimpanzee groups the hormone oxytocin enhances the social affiliation among members of the same group. The high costs of individuals going to war is perplexing. Individuals are willing to suffer costs in order to benefit their own group, through cooperating and supporting their fellow group members and acting with hostility towards the out-group.
